Recent advances in the management of lung cancer
Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However, the past 10 years have seen important advances in treatment and diagnosis which have translated into the first improvements seen in lung cancer survival. This review highlights the major advances in treat...
Gespeichert in:
| Veröffentlicht in: | Clinical medicine (London, England) England), 2018-04, Vol.18 (2), p.s41-s46 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | s46 |
|---|---|
| container_issue | 2 |
| container_start_page | s41 |
| container_title | Clinical medicine (London, England) |
| container_volume | 18 |
| creator | Jones, Gavin S Baldwin, David R |
| description | Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However, the past 10 years have seen important advances in treatment and diagnosis which have translated into the first improvements seen in lung cancer survival. This review highlights the major advances in treatments with curative intent, systemic targeted therapies, palliative care and early diagnosis in lung cancer. We discuss the pivotal research that underpins these new technologies/strategies and their current position in clinical practice. |
| doi_str_mv | 10.7861/clinmedicine.18-2-s41 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2561985914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S147021182400085X</els_id><sourcerecordid>2561985914</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-ea58da522a9f173cfbbee53ad2d98fcac4e9d6a7f079dea7b152d7515f4d3d803</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlZ_grLgeWuSTXaTk0jxCwqC6Dlkk0lNabM12S34702tijdPMzDPO8M8CJ0TPG1ETa7Myoc1WG98gCkRJS0TIwdoTFhTlUzI6vCrxyUlRIzQSUpLjAlnsj5GIyobjLGkY4SfwUDoC223OhhIhQ9F_wbFWge9gPVu1LliNYRFYXZAPEVHTq8SnH3XCXq9u32ZPZTzp_vH2c28NIzhvgTNhdWcUi0daSrj2haAV9pSK4Uz2jCQttaNw420oJuWcGobTrhjtrICVxN0ud-7id37AKlXy26IIZ9UlNdECi4JyxTfUyZ2KUVwahP9WscPRbDaeVJ_PSkiFFXZU85dfG8f2jz9Tf2IycD1HoD849ZDVMl4yAKsj2B6ZTv_z4lPISN-VQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2561985914</pqid></control><display><type>article</type><title>Recent advances in the management of lung cancer</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>Jones, Gavin S ; Baldwin, David R</creator><creatorcontrib>Jones, Gavin S ; Baldwin, David R</creatorcontrib><description>Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However, the past 10 years have seen important advances in treatment and diagnosis which have translated into the first improvements seen in lung cancer survival. This review highlights the major advances in treatments with curative intent, systemic targeted therapies, palliative care and early diagnosis in lung cancer. We discuss the pivotal research that underpins these new technologies/strategies and their current position in clinical practice.</description><identifier>ISSN: 1470-2118</identifier><identifier>EISSN: 1473-4893</identifier><identifier>DOI: 10.7861/clinmedicine.18-2-s41</identifier><identifier>PMID: 29700092</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Ablation ; Cancer therapies ; Chemotherapy ; curative treatment ; Early Diagnosis ; Epidermal growth factor ; Humans ; Lung cancer ; lung cancer management ; Lung Neoplasms - diagnosis ; Lung Neoplasms - pathology ; Lung Neoplasms - therapy ; Medical prognosis ; Metastasis ; Mortality ; Neoplasm Staging ; Radiation therapy ; targeted therapies ; Thoracic surgery ; Tomography ; Tumors</subject><ispartof>Clinical medicine (London, England), 2018-04, Vol.18 (2), p.s41-s46</ispartof><rights>2018 © 2018 THE AUTHORS. Published by Elsevier Limited on behalf of the Royal College of Physicians.</rights><rights>Royal College of Physicians 2018. All rights reserved.</rights><rights>Copyright Royal College of Physicians Apr 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-ea58da522a9f173cfbbee53ad2d98fcac4e9d6a7f079dea7b152d7515f4d3d803</citedby><cites>FETCH-LOGICAL-c440t-ea58da522a9f173cfbbee53ad2d98fcac4e9d6a7f079dea7b152d7515f4d3d803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29700092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jones, Gavin S</creatorcontrib><creatorcontrib>Baldwin, David R</creatorcontrib><title>Recent advances in the management of lung cancer</title><title>Clinical medicine (London, England)</title><addtitle>Clin Med (Lond)</addtitle><description>Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However, the past 10 years have seen important advances in treatment and diagnosis which have translated into the first improvements seen in lung cancer survival. This review highlights the major advances in treatments with curative intent, systemic targeted therapies, palliative care and early diagnosis in lung cancer. We discuss the pivotal research that underpins these new technologies/strategies and their current position in clinical practice.</description><subject>Ablation</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>curative treatment</subject><subject>Early Diagnosis</subject><subject>Epidermal growth factor</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>lung cancer management</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - therapy</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Mortality</subject><subject>Neoplasm Staging</subject><subject>Radiation therapy</subject><subject>targeted therapies</subject><subject>Thoracic surgery</subject><subject>Tomography</subject><subject>Tumors</subject><issn>1470-2118</issn><issn>1473-4893</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkE1LAzEQhoMotlZ_grLgeWuSTXaTk0jxCwqC6Dlkk0lNabM12S34702tijdPMzDPO8M8CJ0TPG1ETa7Myoc1WG98gCkRJS0TIwdoTFhTlUzI6vCrxyUlRIzQSUpLjAlnsj5GIyobjLGkY4SfwUDoC223OhhIhQ9F_wbFWge9gPVu1LliNYRFYXZAPEVHTq8SnH3XCXq9u32ZPZTzp_vH2c28NIzhvgTNhdWcUi0daSrj2haAV9pSK4Uz2jCQttaNw420oJuWcGobTrhjtrICVxN0ud-7id37AKlXy26IIZ9UlNdECi4JyxTfUyZ2KUVwahP9WscPRbDaeVJ_PSkiFFXZU85dfG8f2jz9Tf2IycD1HoD849ZDVMl4yAKsj2B6ZTv_z4lPISN-VQ</recordid><startdate>201804</startdate><enddate>201804</enddate><creator>Jones, Gavin S</creator><creator>Baldwin, David R</creator><general>Elsevier Ltd</general><general>Royal College of Physicians</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201804</creationdate><title>Recent advances in the management of lung cancer</title><author>Jones, Gavin S ; Baldwin, David R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-ea58da522a9f173cfbbee53ad2d98fcac4e9d6a7f079dea7b152d7515f4d3d803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Ablation</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>curative treatment</topic><topic>Early Diagnosis</topic><topic>Epidermal growth factor</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>lung cancer management</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - therapy</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Mortality</topic><topic>Neoplasm Staging</topic><topic>Radiation therapy</topic><topic>targeted therapies</topic><topic>Thoracic surgery</topic><topic>Tomography</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jones, Gavin S</creatorcontrib><creatorcontrib>Baldwin, David R</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>UK & Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical medicine (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jones, Gavin S</au><au>Baldwin, David R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent advances in the management of lung cancer</atitle><jtitle>Clinical medicine (London, England)</jtitle><addtitle>Clin Med (Lond)</addtitle><date>2018-04</date><risdate>2018</risdate><volume>18</volume><issue>2</issue><spage>s41</spage><epage>s46</epage><pages>s41-s46</pages><issn>1470-2118</issn><eissn>1473-4893</eissn><abstract>Historically, the prognosis for individuals diagnosed with lung cancer has been bleak. However, the past 10 years have seen important advances in treatment and diagnosis which have translated into the first improvements seen in lung cancer survival. This review highlights the major advances in treatments with curative intent, systemic targeted therapies, palliative care and early diagnosis in lung cancer. We discuss the pivotal research that underpins these new technologies/strategies and their current position in clinical practice.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29700092</pmid><doi>10.7861/clinmedicine.18-2-s41</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1470-2118 |
| ispartof | Clinical medicine (London, England), 2018-04, Vol.18 (2), p.s41-s46 |
| issn | 1470-2118 1473-4893 |
| language | eng |
| recordid | cdi_proquest_journals_2561985914 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; Journals@Ovid Complete |
| subjects | Ablation Cancer therapies Chemotherapy curative treatment Early Diagnosis Epidermal growth factor Humans Lung cancer lung cancer management Lung Neoplasms - diagnosis Lung Neoplasms - pathology Lung Neoplasms - therapy Medical prognosis Metastasis Mortality Neoplasm Staging Radiation therapy targeted therapies Thoracic surgery Tomography Tumors |
| title | Recent advances in the management of lung cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A58%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20advances%20in%20the%20management%20of%20lung%20cancer&rft.jtitle=Clinical%20medicine%20(London,%20England)&rft.au=Jones,%20Gavin%20S&rft.date=2018-04&rft.volume=18&rft.issue=2&rft.spage=s41&rft.epage=s46&rft.pages=s41-s46&rft.issn=1470-2118&rft.eissn=1473-4893&rft_id=info:doi/10.7861/clinmedicine.18-2-s41&rft_dat=%3Cproquest_cross%3E2561985914%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2561985914&rft_id=info:pmid/29700092&rft_els_id=S147021182400085X&rfr_iscdi=true |